TABELLA IV -.
Probabilità di transizione associate agli stati di salute nella fase acuta
| Trattamento | NoNC | aStroke | aMI | Morte |
|---|---|---|---|---|
| PEX e immunosoppressione | 79,10% | 3,90% | 3,80% | 13,20% |
| Caplacizumab + PEX e immunosoppressione | 93,40% | 2,70% | 3,90% | 0,00% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.